NCT00109135View on ClinicalTrials.gov

A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Smoking
Interventions
DRUG

taranabant

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00109135 - A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007) | Biotech Hunter | Biotech Hunter